SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-170374
Filing Date
2022-06-09
Accepted
2022-06-08 19:39:55
Documents
12
Period of Report
2022-06-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d366052d8k.htm   iXBRL 8-K 26169
  Complete submission text file 0001193125-22-170374.txt   148217

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220607.xsd EX-101.SCH 2892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220607_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220607_pre.xml EX-101.PRE 11285
6 EXTRACTED XBRL INSTANCE DOCUMENT d366052d8k_htm.xml XML 3334
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 221004648
SIC: 2834 Pharmaceutical Preparations